Calcification causes Hypertension

From this research we know that
3.8
Vitamin K increases Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Vitamin K increases Bone density
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Anticoagulant causes Calcification
(BioMindmap Proof Quality is Acceptable.) +1
3.6
Calcification causes Hypertension
(BioMindmap Proof Quality is Acceptable.) +1
3.9
Anticoagulant lowers Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.8
Anticoagulant mutually affect Vitamin K
(BioMindmap Proof Quality is Acceptable.) +1

From this research we know that
3.8
Vitamin K increases Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Vitamin K increases Bone density
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Anticoagulant causes Calcification
(BioMindmap Proof Quality is Acceptable.) +1
3.6
Calcification causes Hypertension
(BioMindmap Proof Quality is Acceptable.) +1
3.9
Anticoagulant lowers Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.8
Anticoagulant mutually affect Vitamin K
(BioMindmap Proof Quality is Acceptable.) +1

Recent studies found a clear association between long-term oral (or intravenous) anticoagulant treatment (OAC) and reduced bone quality due to reduction of active osteocalcin. OAC might lead to an increased incidence of fracture, reduced bone mineral density or content, osteopenia, and increased serum levels of undercarboxylated osteocalcin.
en.wikipedia.org/wiki/Vitamin_K2

From this research we know that
3.8
Vitamin K increases Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Vitamin K increases Bone density
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Anticoagulant causes Calcification
(BioMindmap Proof Quality is Acceptable.) +1
3.6
Calcification causes Hypertension
(BioMindmap Proof Quality is Acceptable.) +1
3.9
Anticoagulant lowers Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.8
Anticoagulant mutually affect Vitamin K
(BioMindmap Proof Quality is Acceptable.) +1

2012

Vitamin K-Dependent Carboxylation of Osteocalcin: Friend or Foe?
Caren M. Gundberg, Jane B. Lian, Sarah L. Booth
In humans, the percentage of the circulating osteocalcin that is not γ-carboxylated (percent ucOC) is used as a biomarker of vitamin K status. In contrast, when ucOC is not corrected for total osteocalcin, the interpretation of this measure is confounded by osteoblastic activity, independent of vitamin K.

vitamin K decreases ucOC.
ncbi.nlm.nih.gov/pmc/articles/PMC3648715
Read 10.3945/an.112.001834

From this research we know that
3.8
Vitamin K increases Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Vitamin K increases Bone density
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Anticoagulant causes Calcification
(BioMindmap Proof Quality is Acceptable.) +1
3.6
Calcification causes Hypertension
(BioMindmap Proof Quality is Acceptable.) +1
3.9
Anticoagulant lowers Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.8
Anticoagulant mutually affect Vitamin K
(BioMindmap Proof Quality is Acceptable.) +1

From this research we know that
3.8
Vitamin K increases Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Vitamin K increases Bone density
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Anticoagulant causes Calcification
(BioMindmap Proof Quality is Acceptable.) +1
3.6
Calcification causes Hypertension
(BioMindmap Proof Quality is Acceptable.) +1
3.9
Anticoagulant lowers Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.8
Anticoagulant mutually affect Vitamin K
(BioMindmap Proof Quality is Acceptable.) +1

1999

Changes in bone density after exposure to oral anticoagulants: a meta-analysis.
Caraballo PJ, et al.
Oral anticoagulants are putative risk factors for osteoporosis, but observational cross-sectional studies describing their effects on bone mineral density have reported conflicting results, prospective studies are not available, and randomized trials are not feasible.

Keywords: Administration, Oral;Age;Anticoagulants;Bone Density;Cross-Sectional Studies;Female;Femur;Femur Neck;Humans;Lumbar Vertebrae;Male;Middle Age;Radius;Time Factors
ncbi.nlm.nih.gov/pubmed/10550464
Read sci-hub

From this research we know that
3.8
Vitamin K increases Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Vitamin K increases Bone density
(BioMindmap Proof Quality is Acceptable.) +1
3.7
Anticoagulant causes Calcification
(BioMindmap Proof Quality is Acceptable.) +1
3.6
Calcification causes Hypertension
(BioMindmap Proof Quality is Acceptable.) +1
3.9
Anticoagulant lowers Osteocalcin
(BioMindmap Proof Quality is Acceptable.) +1
3.8
Anticoagulant mutually affect Vitamin K
(BioMindmap Proof Quality is Acceptable.) +1